Additional file 3 of Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation

Additional file 3: Tab. S2. Differentially methylated CpGs in iPSCs versus iMSCs (WT or DNMT3A knockouts). CpG sites that are either 50% hypo- or hypermethylated in DNMT3A wildtype, exon 2-/-, exon 19-/-, or exon 23-/- iMSCs compared to their iPSC counterparts with associated genes, gene groups, relation to CpG islands, chromosomes, positions, mean beta-values of the knockout and wildtype cells, and the difference in methylation between knockout and wildtype.